To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...

Implement targeted therapies in treatment plans to eradicate Demodex and improve outcomes in patients with Demodex ...

Schulz: When shaping the International Glaucoma Symposium 2026 agenda, we intentionally built a balanced program that reflects both core clinical practice and the rapid evolution of technology in ...

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod ...

The FDA approved re-administration of iDose TR for patients with healthy corneas, enhancing treatment flexibility for ...

Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa using AAV-based delivery. The trial is a collaboration with Cleveland Clinic ...

For patients for whom surgery is indicated but who are opposed to undergoing glaucoma surgery, he may suggest a different ...

The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...

Retinal imaging during ROP screening can predict bronchopulmonary dysplasia and pulmonary hypertension in preterm infants, ...

A study aimed to compare corneal topographic and specular microscopic parameters both before and after patients received the ...